Henry Mentz
Houston, TXNPI 1821163429
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $18,419 of the $27,284 with a category attached, or 67.5%. 18 manufacturers reported payments, led by Integra Lifesciences Corporation at 38.5% of the total.
Across 239 payments — averaging $114.16 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Integra Lifesciences Corporation$11K
- Merz North America, Inc.$4K
- Sientra, Inc.$3K
- Revance Therapeutics, Inc.$3K
- AbbVie$2K
- Motiva USA, LLC$2K
- plus $3K from 12 others
What the payments were for
- Consulting fees$8,84032%
- Food & beverage$18,41968%
- Education$250%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Integra Lifesciences Corporation | 44 | $10,514 |
| Merz North America, Inc. | 22 | $4,007 |
| Sientra, Inc. | 28 | $2,980 |
| Revance Therapeutics, Inc. | 37 | $2,759 |
| AbbVie(2 entities) | 41 | $2,233 |
| Motiva USA, LLC | 21 | $1,766 |
| Mentor Worldwide LLC | 13 | $1,116 |
| Davol Inc. | 5 | $593 |
| Bard Peripheral Vascular, Inc. | 4 | $467 |
| Tepha Inc | 4 | $208 |
| Galderma Laboratories, L.p. | 7 | $194 |
| Musculoskeletal Transplant Foundation Inc. | 1 | $121 |
| Acelrx Pharmaceuticals, Inc. | 1 | $120 |
| Johnson & Johnson | 7 | $116 |
| TELA Bio, Inc. | 1 | $37 |
| KCI USA, Inc. | 1 | $23 |
| Biotissue Holdings Inc. | 1 | $15 |
| Medline Industries LP | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- SURGIMEND$5,767
- CODMAN CERTAS$5,490
- INTEGRA$3,903
- OMNIGRAFT$3,627
- SIENTRA HIGH STRENGTH COHESIVE SILICONE GEL BREAST IMPLANT$2,119
- DAXXIFY$1,410
- Motiva Implant Matrix$1,025
- MENTOR MemoryGel Resterilizable Gel Sizer$678
- NATRELLE SALINE-FILLED BREAST IMPLANTS$658
- Phasix Mesh$469
- NATRELLE$405
- BOTOX COSMETIC$298
- INTEGRA DERMAL REGENERATION TEMPLATE$277
- DuraSorb Monofilament Mesh$268
- MemoryGel Breast Implants$223
- MENTOR CPX 2 Breast Tissue Expander$149
- GalaFLEX$134
- DSUVIA$120
- ARTOURA Breast Tissue Expander$106
- AGENTO$102
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Clonidine | 23 | $900 |
| Famciclovir | 25 | $523 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 37 | $459 |
| Methylprednisolone | 44 | $268 |
| Ondansetron Hcl | 47 | $247 |
| Mupirocin | 22 | $217 |
| Alprazolam | 44 | $151 |
| Cephalexin | 48 | $142 |
| Doxycycline Monohydrate | 16 | $112 |
| Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim | 13 | $36 |
Paid to pharmacies, not to this prescriber.
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.